Physician profile
Na Li
NPI 1588922041
$2,527.01
in general payments reported to CMS, 2019-2025
16 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $211 · 2021: $363 · 2022: $575 · 2023: $401 · 2024: $608 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,121.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $670.71 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $532.91 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $256.86 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $210.09 | 2019-2024 | Dificid, Zerbaxa, Recarbrio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.20 | 2020-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $148.92 | 2020-2022 | |
| Abbvie INC. | $122.27 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.98 | 2020-2024 | Xifaxan |
| Paratek Pharmaceuticals, INC. | $71.11 | 2022 | |
| Alexion Pharmaceuticals, INC. | $60.49 | 2023-2025 | Ultomiris |
| E.R. Squibb & Sons, L.L.C. | $51.59 | 2019-2022 | |
| Sk Life Science, INC. | $38.00 | 2025 | |
| Melinta Therapeutics, LLC | $36.44 | 2021-2022 | |
| Abbott Laboratories | $24.94 | 2024 | Mitraclip |
| Bayer Healthcare Pharmaceuticals INC. | $21.20 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $19.30 | 2023 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Na Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.